M2A MAGNUM HIP SYSTEM 139254Recalls & reported problems

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00880304428027), received between Jan 27, 2020 and Jan 27, 2020 — classified as 1 injury.

The most frequently reported specific device problem is “Material Erosion” (1 report).

1 other recall cover devices cleared under the same FDA submission (K101336); they may or may not involve this specific model.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

• InjuryJan 27, 2020Material Erosion; Material Erosion

  UPON RECEIPT OF ADDITIONAL INFORMATION, IT HAS BEEN DETERMINED THAT THIS DEVICE DID NOT CAUSE OR CONTRIBUTE TO THE REPORTED EVENT. THE INITIAL REPORT WAS FORWARDED IN ERROR AND SHOULD BE VOIDED.

  Patient problems: Erosion; Osteolysis; Osteopenia/ Osteoporosis; Pain

  MAUDE report 9631390 ↗

Recalls under the same FDA submission

These recalls involve devices cleared under K101336. One submission often covers many models, so check the product and lot details in each record.

• Z-1465-2013 · Apr 26, 2013 · Terminated
  Active Articulation E1. Intended for use with either primary or revision hip arthroplasty.